Ticker
VIVSCompany Name
VIVOSIM LABS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earning Before Interest & Taxes (EBIT) | EBIT Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -1.97M | -1389.44% | $ 142K |
3/31/2025 | $ -2.48M | -1719.44% | $ 144K |
12/31/2024 | $ -12.38M | -10145.9% | $ 122K |
9/30/2024 | $ -12.54M | -12174.76% | $ 103K |
6/30/2024 | $ -13.98M | -19157.53% | $ 73K |
3/31/2024 | $ -14.67M | -13457.8% | $ 109K |
12/31/2023 | $ -19.08M | -7885.54% | $ 242K |
9/30/2023 | $ -18.74M | -5093.21% | $ 368K |
6/30/2023 | $ -18.07M | -4060.67% | $ 445K |
3/31/2023 | $ -17.26M | -4664.05% | $ 370K |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT / Revenues
(=) EBIT %
EBIT % for VIVOSIM LABS INC is calculated as follows: EBIT [ $ -17.81M ] / Revenues [ $ 298K ]
(=) EBIT % [ -5976.51% ]
Minimum
Jun 30, 2024
Maximum
Dec 31, 2022
Average
Median
filtered constituents | 3.26K |
---|---|
min | -73.16% |
max | 83.08% |
average | 9.55% |
median | 9.01% |
std | 23.96% |